Home - Specialty Drug Management Innovations for Health Plans - October 11-12, 2018 * Philadelphia, PA

Industry experts predict that specialty pharmaceuticals could account for up to 47% of a health plan�s total drug spend by 2020.

The specialty drug marketplace is expected to grow exponentially over the next several years both in utilization and in spend. Such rapid expansion presents a host of new challenges-- and opportunities-- for payer organizations and PBMs. This conference explores key advances in specialty pharmacy for optimizing cost management, medication adherence, patient engagement, benefit design, site of care channels, technology and developing new collaborations with industry stakeholders.

2018 Case Studies & Value Deliverables

Our comprehensive conference agenda provides learning opportunities through carefully curated case studies, panels, and small group roundtable sessions.

Discover in-depth solutions and presentations from health plan professionals, including PBM and PBA specialists.

Navigating the Specialty Drug Lexicon and how to effectively integrate specialty pharmacy into your formulary
Current PBM business model and shifts in primary sources of gross profit
Overview of Cost Drivers and Control Strategies and how to accomplish greater impact on Cost Reductions
Utilization Management Reform and Practices
Designing and implementing a Successful Medical Benefit Drug Management Plan
Medical Benefit vs. Pharmacy Benefit
Managing rare conditions with the ascent of Orphan Drugs
Gene Therapy Pipelines
Improving Adherence
Seizing Key Opportunities in Specialty Lite

Examine thought-provoking case studies and benefit from small-group, interactive discussions while networking with peers and experts as you share strategies to tackle key challenges facing specialty pharmacy:

Analyzing Top Specialty Drug Growth Categories and Strategies to Balance Costs vs. Outcomes
Latest Advances and Winning Strategies for Favorable Oncology Patient Outcomes
New ways to Fight HIV and how to best promote adherence and positive outcomes

Autoimmune Disorders Pipeline Update and why they should be added to your formulary

Inflammatory Diseases Assessment: Health plan utilization, cost, member cost-share, pharmacy and medical benefit spending